Dr. Susan Bates, MD

Dr. Susan Bates, MD

Save
Medical Oncology  |  
Female  |  
64 y/o

Accepting new patients

Dr. Susan Bates, MD is a medical oncology doctor who practices in New York, NY. She is 64 years old and has been practicing for 39 years. Read her story

Columbia University Medical Center Division of Hematology/Oncology

161 Fort Washington Ave Fl 9

New York, NY 10032
Get Directions

Accepted insurance

  • Commercial Insurance Company
  • Empire Blue Cross Blue Shield
  • MagnaCare
  • Oscar Insurance Corporation
  • POMCO Group

Learn about Dr. Bates

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you

Top Care Areas

new

See how frequently Dr. Bates performs your care needs compared to other doctors.

Pancreatic Cancer
very high
more than 92% of peers
Cancer
normal
more than 62% of peers
Gastrointestinal Diseases
normal
more than 47% of peers

Dr. Bates's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

We're trying something new with Top Care Areas.Was it helpful for you?YesNo

Dr. Bates' bio

This content was provided by Dr. Bates "Dr. Susan Bates received her M.D. degree from the University of Arkansas School of Medicine. She completed her clinical training in internal medicine at Georgetown University in Washington, D.C., and in medical oncology at the National Cancer Institute (NCI) in Bethesda, MD. Dr. Bates was a Lead Clinical Investigator and Head of the Molecular Therapeutics Section in the Developmental Therapeutics Branch of the Center for Cancer Research before moving to Columbia University in August 2015. During her years at the NCI, Dr. Bates led a highly successful translational research program focused on mechanisms of multidrug resistance and approaches to evaluate and improve the activity of epigenetic modifying agents. Her laboratory was among the first to clone the multidrug transporter ABCG2, eventually characterizing its function and its role in chemo-resistance and chemo-protection. This effort built upon earlier work elaborating the role of the multi-drug transporter P-glycoprotein that had defined the drug sensitivity profiles of cell lines in vitro, particularly in the NCI-60 cell line panel. The latter observation continues to impact how the NCI-60 cell line panel is used in drug discovery, and helped her identify a novel agent, at that time known as depsipeptide. Dr. Bates brought this drug to the clinic and after completing its phase I testing, served as Principal Investigator of a multi-institutional, international Phase II study of romidepsin (depsipeptide) in cutaneous and peripheral T-cell lymphoma. Working with Gloucester Pharmaceuticals, the data from this study were included in New Drug Applications (NDA) to the U.S. Food & Drug Administration (FDA). This partnership led to approval by the FDA of romidepsin for two indications - initially for cutaneous T-cell lymphoma and later for peripheral T-cell lymphoma. Dr. Bates' current interests are both laboratory and clinical in nature. Her laboratory efforts include laboratory and translational studies on drug resistance in T-cell lymphomas and advanced solid tumors including breast, pancreatic, neuroendocrine, renal and lung cancers. Her work is dedicated to new drug development, and finding antineoplastic agents that, alone or in combination with other anticancer agents, improve the options available for difficult to treat cancers. Emanating from the clinical and translational development of romidepsin, a histone deacetylase (HDAC) inhibitor, a current focus is on epigenetic therapies, and the development of combination therapies to use with HDAC inhibitors in refractory advanced cancers, including solid tumors. She also has a special interest in drug delivery and drug distribution and the role of the blood brain barrier in creating a sanctuary site for cancers that metastasize to the brain. Clinically, her goal has always been to translate ideas from the laboratory to clinical trials, an effort that has proven very successful. Clinically she seeks to develop combination therapies with histone deacetylase inhibitors for the therapy of solid tumors; and to develop therapies to treat central nervous system metastases, a complication of cancer that is becoming a greater problem as patients live longer with cancer."

More

Read More

Care Philosophy

This content was provided by Dr. Bates "We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person. "
2

Specialties

  • Medical Oncology
  • Internal Medicine
2

Board Certifications

  • Internal Medicine
    Accredited by: American Board of Internal Medicine*
  • Medical Oncology
    Accredited by: American Board of Internal Medicine*
24

Conditions Treated

  • Anemia
  • Autoimmune Diseases
  • Blood Cancer
  • Blood Disorders
  • Brain Metastasis
  • Breast Cancer
  • Breast Diseases
  • Cancer
  • Carcinoma in Situ
  • Cervical Cancer
  • Cholangiocarcinoma
  • Gallbladder Cancer
  • Gallbladder and Biliary Tract Cancer
  • Gastrointestinal Diseases
  • Liver Cancer
  • Lung Cancer
  • Neutropenia
  • Pancreatic Cancer
  • Pulmonary Disease
  • Secondary Malignancies
  • Stomach Cancer
  • Stomach Diseases
  • Stomach and Small Intestine Cancer
  • Vascular Disease
1

Procedures

  • Cancer Treatment

Background Check

0 Malpractice Claims

No malpractice history found for New York.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • University Of Arkansas For Medical Sciences
    Medical School | Graduated 1978
  • Georgetown University Medical Center
    Residency Hospital | Completed 1981
  • University Arkansas Medical Center
    Residency Hospital | Completed 1980
  • National Institutes Of Health National Cancer Institute
    Fellowship Hospital | Completed 1984

Awards & Recognition

Awards & Honors
  • Healthgrades Honor Roll
Media & Publications

Dr. Bates has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Bates does not have any memberships or affiliations listed. If you are Dr. Bates and would like to add memberships or affiliations, please update your profile.

Dr. Bates' Reviews

Help millions of people find the right doctor. Share your experience today!
Are you Dr. Bates?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Visit Dr. Bates

Now Accepting New Patients
Dr. Bates accepts 5 insurance carriers
  • Commercial Insurance Company
  • Empire Blue Cross Blue Shield
  • MagnaCare
  • Oscar Insurance Corporation
  • POMCO Group

*Please verify this information when scheduling an appointment.

Hospitals where Dr. Bates has admitting privileges

View Hospital Profile

More Oncology Specialists like Dr. Bates at Columbia University Medical Center Division of Hematology/Oncology

Hematology Specialist
(9)
Medical Oncology Specialist
(4)
Medical Oncology Specialist
(15)
Medical Oncology Specialist
Medical Oncology Specialist
Hematology Specialist
(5)